S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)

These Were The Ten Best Performing IPOs In Q1 2022

Thursday, April 21, 2022 | ValueWalk

IPO market witnessed a slowdown in Q1 2022, and there are several reasons for this. These reasons include rising geopolitical tensions, rising commodity and energy prices, rising inflation, stock market volatility and price correction in over-valued stocks from recent IPOs. Despite the grim scenario, 37 deals were completed in the U.S. in Q1 2022, raising $2.4 billion in proceeds.  Let’s take a look at the ten best performing IPOs in Q1 2022.

Q1 2022 hedge fund letters, conferences and more

Ten Best Performing IPOs In Q1 2022

We have used the quarterly return data (from finviz.com) of companies that went public in Q1 2022 to rank the ten best performing IPOs in Q1 2022. Following are the ten best IPOs in Q1 2022:

  1. Green Visor Financial Technology Acquisition (1%)

Founded in 2021 and headquartered in San Francisco, Green Visor Financial Technology Acquisition (NASDAQ:GVCIU) is a blank check company that has been formed for effecting a merger, share purchase, asset acquisition and other similar transactions. Its shares are currently trading over $10 and are up almost 1% in the last one month.

  1. Bullpen Parlay Acquisition (2%)

Bullpen Parlay Acquisition Co (NASDAQ:BPAC) is a blank check company that has been formed for the purpose of effecting a merger, asset acquisition, stock purchase, or other similar transactions. Its shares are currently trading over $9.90 and are up almost 1% in the last one month.


  1. NorthView Acquisition (2%)

Founded in 2021 and headquartered in New York, it is a blank check company that is formed to effect a merger, asset acquisition, share purchase, or other similar transactions. Northview Acquisition Corp (NASDAQ:NVAC) shares are currently trading over $9.80.

  1. Mount Rainier Acquisition (2%)

Founded in 2021 and headquartered in New York, it is a blank check company or a special purpose acquisition company formed with the purpose of effecting a merger, asset acquisition or other similar transactions. Mount Rainier Acquisition Corp (NASDAQ:RNER) shares are up almost 1% in the last one month. Its shares are currently trading over $10.

  1. CareCloud (4%)

Founded in 1999 and headquartered in Somerset, N.J., it is a healthcare information technology (IT) company that offers an integrated suite of proprietary cloud-based electronic health records and practice management solutions. CareCloud Inc (NASDAQ:MTBC) shares are down almost 3% in the last one month and almost 1% in the last five days. Its shares are currently trading over $25.70. CareCloud completed the offering of Series B Preferred Stock in early February.

  1. CinCor Pharma (13%)

Founded in 2018 and headquartered in Boston, it is a clinical-stage biopharmaceutical company that develops clinical treatments for hypertension and other cardio-renal diseases. CinCor Pharma Inc (NASDAQ:CINC) shares are up almost 19% in the last one month but are down over 4% in the last five days. The company went public in the first week of January.

  1. Presidio Property Trust (22%)

Founded in 1999 and headquartered in San Diego, it is a self-managed real estate investment trust that invests across a multi-tenant portfolio of real estate assets. Presidio Property Trust Inc (NASDAQ:SQFT) shares are down over 1% in the last one month. Its shares are currently trading over $0.20.

  1. Credo Technology Group Holding (24%)

Founded in 2014 and headquartered in San Jose, Calif., this company offers connectivity solutions and products for the data infrastructure market, such as integrated circuits, active electrical cables and more. Credo Technology Group Holding Ltd (NASDAQ:CRDO) shares are down over 21% in the last one month. Its shares are currently trading over $11.90, giving it a market cap of over $1.5 billion. Credo Technology Group went public in the last week of January.

  1. Constellation Energy (38%)

Headquartered in Baltimore, this company generates, supplies and markets clean energy electricity, as well as offers renewable energy products and solutions. Constellation Energy Corp (NASDAQ:CEG) shares are up almost 25% in the last one month and almost 5% in the last five days. Its shares are currently trading over $64, giving it a market cap of over $21 billion. Constellation Energy went public in early February.

  1. Nuvectis Pharma (116%)

Founded in 2020 and headquartered in Fort Lee, N.J., it is a preclinical stage biopharmaceutical firm that focuses on novel targeted small molecule therapeutics for treating cancer. Nuvectis Pharma Inc (NASDAQ:NVCT) shares are up almost 28% in the last one month but are down almost 5% in the last five days. Its shares are currently trading over $9.50, giving it a market cap of over $120 million. Nuvectis Pharma went public in early February.


7 Travel Stocks That Will Benefit as Covid Restrictions End

From sea to shining sea, the green shoots of a re-opening are rapidly turning into a forest of lush growth. That may sound a bit over the top, but after two long years, it appears that 2022 will bring a return to travel that resembles pre-pandemic levels. And if you still think that's hyperbole, consider this:

The Institute for Health Metrics and Evaluation at the University of Washington estimates that 73% of Americans are currently immune to the omicron variant of Covid-19. At that level, many experts believe that future surges will be less disruptive. And even Dr. Anthony Fauci believes it's time for Americans to turn the page.

And that's why investors should start looking at travel stocks. To be fair, this isn't a sector where investors will find many undervalued stocks. In fact, many skeptics may say that these stocks have future growth priced in.

That's a theory that is about to be tested in a big way. This is why we've done some digging and are presenting you with seven stocks that appear to offer some intriguing value as Americans make their travel plans.



View the "7 Travel Stocks That Will Benefit as Covid Restrictions End".


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Bullpen Parlay Acquisition (BPAC)
0 of 5 stars
$9.87-0.3%N/AN/AN/AN/A
NorthView Acquisition (NVAC)
0 of 5 stars
$9.87+0.3%N/AN/AN/AN/A
Mount Rainier Acquisition (RNER)
0 of 5 stars
$9.99-0.1%N/AN/AN/AN/A
CareCloud (MTBC)
2.3564 of 5 stars
$3.97+0.5%N/A-6.40Buy$15.33
CinCor Pharma (CINC)
1.8667 of 5 stars
$15.13-11.6%N/AN/ABuy$29.00
Presidio Property Trust (SQFT)
1.7583 of 5 stars
$3.04+0.3%13.82%-6.08Buy$2.75
Credo Technology Group (CRDO)
1.9314 of 5 stars
$10.00+3.1%N/AN/ABuy$20.75
Nuvectis Pharma (NVCT)
2.0333 of 5 stars
$15.50-13.5%N/AN/ABuy$21.00
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.